rs63751086
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM5PP3_ModeratePP5
The NM_001171.6(ABCC6):c.3941G>A(p.Arg1314Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000571 in 1,577,280 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1314W) has been classified as Pathogenic.
Frequency
Consequence
NM_001171.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABCC6 | NM_001171.6 | c.3941G>A | p.Arg1314Gln | missense_variant | 28/31 | ENST00000205557.12 | NP_001162.5 | |
ABCC6 | NM_001351800.1 | c.3599G>A | p.Arg1200Gln | missense_variant | 28/31 | NP_001338729.1 | ||
ABCC6 | NR_147784.1 | n.3603G>A | non_coding_transcript_exon_variant | 26/29 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCC6 | ENST00000205557.12 | c.3941G>A | p.Arg1314Gln | missense_variant | 28/31 | 1 | NM_001171.6 | ENSP00000205557.7 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152118Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000378 AC: 7AN: 185234Hom.: 0 AF XY: 0.0000401 AC XY: 4AN XY: 99670
GnomAD4 exome AF: 0.0000519 AC: 74AN: 1425162Hom.: 0 Cov.: 32 AF XY: 0.0000624 AC XY: 44AN XY: 705614
GnomAD4 genome AF: 0.000105 AC: 16AN: 152118Hom.: 0 Cov.: 31 AF XY: 0.000135 AC XY: 10AN XY: 74302
ClinVar
Submissions by phenotype
Autosomal recessive inherited pseudoxanthoma elasticum Pathogenic:1
Pathogenic, criteria provided, single submitter | research | PXE International | Mar 01, 2021 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1314 of the ABCC6 protein (p.Arg1314Gln). This variant is present in population databases (rs63751086, gnomAD 0.02%). This missense change has been observed in individual(s) with pseudoxanthoma elasticum (PMID: 29722917). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 402332). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCC6 protein function with a positive predictive value of 95%. This variant disrupts the p.Arg1314 amino acid residue in ABCC6. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10835642, 19339160). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Autosomal recessive inherited pseudoxanthoma elasticum;C1867450:Pseudoxanthoma elasticum, forme fruste;C3276161:Arterial calcification, generalized, of infancy, 2 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 23, 2024 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: LeSaux 2001: reported in 1 compound heterozygote individual (/122) with pseudoxanthoma elasticum. No info about the other mutation - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at